Source: Resumos. Conference titles: Annual meeting pancreas club. Unidade: FM
Subjects: TERAPIAS COMPLEMENTARES, NEOPLASIAS PANCREÁTICAS, MODELOS ANIMAIS, HAMSTERS
ABNT
MORIOKA, Cintia Yoko et al. Neoadjuvant and adjuvant therapy with farnesultransferase inhibitor in hamster pancreatic cancer model is it effective? 2004, Anais.. New Orleans: Faculdade de Medicina, Universidade de São Paulo, 2004. p. P26. . Acesso em: 08 maio 2024.APA
Morioka, C. Y., Machado, M. C. C., Saito, S., Ohzawa, K., Godoy, R. S. de, Matheus, A. S., et al. (2004). Neoadjuvant and adjuvant therapy with farnesultransferase inhibitor in hamster pancreatic cancer model is it effective? In Resumos (p. P26). New Orleans: Faculdade de Medicina, Universidade de São Paulo.NLM
Morioka CY, Machado MCC, Saito S, Ohzawa K, Godoy RS de, Matheus AS, Jukemura J, Bacchella T, Arai H, Sakamoto T, Watanabe A. Neoadjuvant and adjuvant therapy with farnesultransferase inhibitor in hamster pancreatic cancer model is it effective? Resumos. 2004 ; P26.[citado 2024 maio 08 ]Vancouver
Morioka CY, Machado MCC, Saito S, Ohzawa K, Godoy RS de, Matheus AS, Jukemura J, Bacchella T, Arai H, Sakamoto T, Watanabe A. Neoadjuvant and adjuvant therapy with farnesultransferase inhibitor in hamster pancreatic cancer model is it effective? Resumos. 2004 ; P26.[citado 2024 maio 08 ]